ConductScience.org, home

Gene · 1063

CENPF: centromere protein F

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CENPF: centromere protein F. Genes, record 1063. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1063

On this page

Gene

Symbol
CENPF
HGNC
Name
centromere protein F
HGNC
NCBI Gene ID
1063
NCBI Gene
HGNC ID
HGNC:1857
HGNC
Ensembl
ENSG00000117724
NCBI Gene
Aliases
CENF, CILD31, PRO1779, STROMS, hcp-1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P49454Centromere protein F3,1140Ensembl, GeneID, HGNC

Source UniProt

Patents33

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1440830P49454Espacenet
EP 4650780 A22025-11-198138P49454Espacenet
EP 4641201 A22025-10-298294P49454Espacenet
EP 4641202 A22025-10-295373P49454Espacenet
JP 2025517969 A2025-06-128294P49454Espacenet
JP 2025517970 A2025-06-128138P49454Espacenet
KR 1020250017231 A2025-02-045373P49454Espacenet
US 12097221 B22024-09-2412P49454Espacenet
JP 2022141755 A2022-09-29201P49454Espacenet
US 11446398 B22022-09-2013889P49454Espacenet

1 to 10 of 33

See all 33 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,492

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCENPF papersNewest fiscal year
P30CA006927Comprehensive Cancer Center Program at Fox Chase172025
P30CA008748Cancer Center Support Grant162025
P30CA068485Cancer Center Support Grant102025
P30CA016672Cancer Center Support Grant82025
P30DK058404Molecular and Cellular Basis for Digestive Diseases52025
R01GM074215Kinetochore Specification and Function52025
P30CA016056Roswell Park Cancer Center Support Grant42025
P30CA021765Cancer Center Support Grant (CCSG)42025
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant42025
P30EY008126Core Grant in Vision Research42025

1 to 10 of 1,492Source NIH's project files

See all 1,492 nih grants

Papers2,501

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
High Infiltration Level of a Prognostic Improvement Associated T Cells Is Favorable for the Prognosis of Patients with Gastric Adenocarcinoma.Digestion202642771562PubTator, text miningPubMed
KDM1A/HDAC2-driven epigenetic dysregulation maintains a drug-resistant, relapse-initiating glioblastoma cell niche at the peri-tumoral margin.Biochem Pharmacol202642685875PubTator, text miningPubMed
PROFET predicts continuous gene expression dynamics from scRNA-seq data to elucidate heterogeneity of cancer treatment responses.Cell Syst202642664975PubTator, text miningPubMed
Immune-related gene signature for predicting biochemical recurrence after RP in prostate cancer subtypes.Discov Oncol202642635880PubTator, text miningPubMed
Unveiling immune-related gene signatures in triple negative breast cancer through integrated transcriptomic analysis.Biomedicine (Taipei)202642483440PubTator, text miningPubMed
Strømme syndrome: the clinical and molecular spectrum associated with variants in CENPF.Eur J Hum Genet202642471516PubTator, text miningPubMed
Heterogeneity characterization and therapeutic marker discovery of endometrial carcinoma using GeoMXT™ digital spatial profiling.J Transl Med202642458520PubTator, text miningPubMed
Molecular effects of ovarian stimulation for fertility preservation in breast cancer: a paired-biopsy analysis.ESMO Open202642413327PubTator, text miningPubMed
Integrative Transcriptomic Analysis Identifies Hypoxia-responsive Cell Cycle Hub Genes as Prognostic Markers in Glioblastoma.Ann Neurosci202642405025PubTator, text miningPubMed
In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer.Cancer Biomark202642333064PubTator, text miningPubMed

1 to 10 of 2,501

See all 2,501 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/1063

GET https://conductscience.org/api/genes/v1/1063/patents?page=2